{
  "main_header": {
    "sid": 271637,
    "name": "Kabra Drugs",
    "stock_name": "Kabra Drugs",
    "full_name": "Kabra Drugs Ltd",
    "name_url": "stocks-analysis/kabra-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.03",
    "chg": 0.23,
    "chgp": "0.89%",
    "dir": 1,
    "prev_price": "25.80",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524322,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE323K01017",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "46.21 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 52,
    "sid": "271637",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/kabra-drugs-271637"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Intimation of Closure iof Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 07 Th March 2026 As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "07-Mar-2026",
      "details": "Outcome of Board Meeting held on 07 th March 2026 as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026",
      "datetime": "26-Feb-2026",
      "details": "Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday March 7 2026 at the Corporate Office of the Company situated at Chennai.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News